Pharmarise Holdings Corporation

Symbol: 2796.T

JPX

659

JPY

Market price today

  • 24.8104

    P/E Ratio

  • -0.9523

    PEG Ratio

  • 7.41B

    MRK Cap

  • 0.02%

    DIV Yield

Pharmarise Holdings Corporation (2796-T) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.16%

Operating Profit Margin

0.03%

Net Profit Margin

0.01%

Return on Assets

0.01%

Return on Equity

0.04%

Return on Capital Employed

0.08%

Company general description and statistics

Sector: Healthcare
Industry: Pharmaceuticals - Retailers
CEO:Mr. Toshimichi Ohno
Full-time employees:1555
City:Tokyo
Address:Sumitomo Nakano Sakue Building
IPO:2007-02-21
CIK:

Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.

General Outlook

When we look at how much money they make before expenses, they keep 0.156% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.026%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.006%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.011% return, is a testament to Pharmarise Holdings Corporation's adeptness in optimizing resource deployment. Pharmarise Holdings Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.040%. Furthermore, the proficiency of Pharmarise Holdings Corporation in capital utilization is underscored by a remarkable 0.079% return on capital employed.

Stock Prices

Pharmarise Holdings Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $649, while its low point bottomed out at $645. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Pharmarise Holdings Corporation's stock market.

Liquidity Ratios

Analyzing 2796.T liquidity ratios reveals its financial health of the firm. The current ratio of 134.81% gauges short-term asset coverage for liabilities. The quick ratio (92.48%) assesses immediate liquidity, while the cash ratio (59.19%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio134.81%
Quick Ratio92.48%
Cash Ratio59.19%

Profitability Ratios

2796.T profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 2.02% underscores its earnings before tax deductions. The effective tax rate stands at 70.96%, revealing its tax efficiency. The net income per EBT, 27.67%, and the EBT per EBIT, 77.49%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 2.60%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin2.02%
Effective Tax Rate70.96%
Net Income per EBT27.67%
EBT per EBIT77.49%
EBIT per Revenue2.60%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.35, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 1858.61% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding92
Days of Inventory Outstanding27
Operating Cycle46.32
Days of Payables Outstanding39
Cash Conversion Cycle7
Receivables Turnover18.59
Payables Turnover9.26
Inventory Turnover13.68
Fixed Asset Turnover8.88
Asset Turnover2.04

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 152.96, and free cash flow per share, 152.96, depict cash generation on a per-share basis. The cash per share value, 452.93, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.03, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share152.96
Free Cash Flow per Share152.96
Cash per Share452.93
Operating Cash Flow Sales Ratio0.03
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio0.17
Short Term Coverage Ratio0.77

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 39.97%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.34, we discern the balance between debt and equity financing. The long-term debt to capitalization, 51.32%, and total debt to capitalization, 57.30%, ratios shed light on its capital structure. An interest coverage of 24.63 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio39.97%
Debt Equity Ratio1.34
Long Term Debt to Capitalization51.32%
Total Debt to Capitalization57.30%
Interest Coverage24.63
Cash Flow to Debt Ratio0.17
Company Equity Multiplier3.36

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -1.37%, indicates top-line expansion, while the gross profit growth, 0.61%, reveals profitability trends. EBIT growth, 21.99%, and operating income growth, 21.99%, offer insights into operational profitability progression.

cards.indicatorcards.value
Revenue Growth-1.37%
Gross Profit Growth0.61%
EBIT Growth21.99%
Operating Income Growth21.99%
EPS Growth4.52%
EPS Diluted Growth38.28%
Weighted Average Shares Growth0.28%
Weighted Average Shares Diluted Growth0.28%
Dividends per Share Growth1.27%
Operating Cash Flow Growth-63.34%
Free Cash Flow Growth-82.27%
10-Year Revenue Growth per Share24.36%
5-Year Revenue Growth per Share-8.38%
3-Year Revenue Growth per Share-2.21%
10-Year Operating CF Growth per Share-64.59%
5-Year Operating CF Growth per Share-48.07%
3-Year Operating CF Growth per Share-21.92%
10-Year Net Income Growth per Share-62.50%
5-Year Net Income Growth per Share308.17%
3-Year Net Income Growth per Share4968.02%
10-Year Shareholders Equity Growth per Share23.54%
5-Year Shareholders Equity Growth per Share17.76%
3-Year Shareholders Equity Growth per Share18.58%
10-Year Dividend per Share Growth per Share40.39%
5-Year Dividend per Share Growth per Share0.71%
3-Year Dividend per Share Growth per Share2.72%
Receivables Growth37.96%
Inventory Growth-11.02%
Asset Growth-3.96%
Book Value per Share Growth5.91%
Debt Growth-7.34%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.95, and the price to book ratio, 0.95, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.14, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 4.22, and price to operating cash flows, 4.28, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.95
Price to Book Ratio0.95
Price to Sales Ratio0.14
Price Cash Flow Ratio4.28
Price Earnings to Growth Ratio-0.95
Enterprise Value Multiple1.14
Price Fair Value0.95
Price to Operating Cash Flow Ratio4.28
Price to Free Cash Flows Ratio4.22
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Pharmarise Holdings Corporation (2796.T) on the JPX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 24.810 in 2024.

What is the ticker symbol of Pharmarise Holdings Corporation stock?

The ticker symbol of Pharmarise Holdings Corporation stock is 2796.T.

What is company IPO date?

IPO date of Pharmarise Holdings Corporation is 2007-02-21.

What is company current share price?

Current share price is 659.000 JPY.

What is stock market cap today?

The market cap of stock today is 7409291206.000.

What is PEG ratio in 2024?

The current -0.952 is -0.952 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1555.